Ohtuvayre® (ensifentrine) - Correct Coding and Coverage

Ohtuvayre® (ensifentrine) is a new inhalation solution approved by the U.S. Food and Drug Administration on June 26, 2024, and is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.